ONKOLOGIK BEMORLARDA KIMYOTERAPIYA BILAN BOGʻLIQ KOʻNGIL AYNISHI VA QUSISH PROFILAKTIKASIDA ZAMONAVIY ANTIEMETIK TERAPIYANING OʻRNI

Authors

  • Ismoilova Gulruh Ulugʻbek qizi Onkologiya va tibbiy radiologiya yo’nalishi 1-kurs ordinatori CAMU

Keywords:

Kalit soʻzlar: onkologiya, kimyoterapiya, CINV, antiemetik terapiya, 5-HT3 antagonistlari, NK1 antagonistlari, olanzapin, deksametazon, profilaktika.

Abstract

Annotatsiya. Kimyoterapiya bilan bogʻliq koʻngil aynishi va qusish (Chemotherapy-Induced Nausea and Vomiting – CINV) onkologik bemorlarda eng koʻp uchraydigan nojoʻya taʼsirlardan biri boʻlib, davolash samaradorligi va bemorlarning hayot sifatiga salbiy taʼsir koʻrsatadi. Zamonaviy antiemetik terapiya xalqaro klinik tavsiyalar asosida kimyoterapiyaning emetogenlik darajasi hamda bemorning individual xavf omillarini hisobga olgan holda tanlanadi. Maqolada CINV profilaktikasida qoʻllanilayotgan 5-HT3 retseptor antagonistlari, NK1 retseptor antagonistlari, deksametazon va olanzapinning klinik ahamiyati tahlil qilindi. Zamonaviy kombinatsiyalangan antiemetik sxemalar oʻtkir va kechikkan koʻngil aynishi hamda qusish holatlarini sezilarli kamaytirishi, bemorlarning kimyoterapiyani toʻliq qabul qilishiga va hayot sifatini yaxshilashga xizmat qilishi aniqlandi.

References

1.European Society for Medical Oncology (ESMO). Clinical Practice Guidelines: Antiemetic Therapy. 2024.

2.Hesketh PJ, Kris MG, Basch E, et al. Antiemetics: ASCO Guideline Update. Journal of Clinical Oncology. 2020;38(24):2782–2797.

3.Jordan K, Chan A, Gralla RJ, et al. 2023 MASCC/ESMO guideline update for the prevention of chemotherapy-induced nausea and vomiting. Support Care Cancer. 2024;32:44.

4.Molassiotis A, Chan A, Yam BM, et al. Evidence-based management of chemotherapy-induced nausea and vomiting. Supportive Care in Cancer. 2021;29:525–538.

5.National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Antiemesis. Version 2025.

6.Navari RM, Aapro M. Antiemetic prophylaxis for chemotherapy-induced nausea and vomiting. New England Journal of Medicine. 2022;386:2305–2315.

7.Navari RM. Pharmacologic management of chemotherapy-induced nausea and vomiting. Expert Opinion on Pharmacotherapy. 2023;24:1259–1271.

8.Rapoport BL, Navari RM, Molassiotis A, et al. MASCC/ESMO recommendations for breakthrough and refractory CINV. Supportive Care in Cancer. 2024.

Downloads

Published

2026-07-08

Conference Proceedings Volume

Section

Articles

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.